Synthesis of a 5-Spirocyclopropyl Deoxyrhamnojirimycin as a Constrained Naringinase Inhibitor

Abstract

A spirocyclopropyl analogue of deoxyrhamnojirimycin has been synthesized in 11 steps and 20% overall yield from l-arabinose. The key step of the reaction path involves titanium-mediated aminocyclopropanation of an l-arabinononitrile derivative. Improvements of the standard reaction conditions were investigated. The use of methyltitanium triisopropoxide as the titanium source allowed the reaction to take place at room temperature and afforded the corresponding cyclopropylamine in 80% yield.

glycosidases - imino sugars - metallacycles - nitriles - spiro compounds - titanium

References

1 Guillerm G. Muzard M. Glapski C. Pilard S. Bioorg. Med. Chem. Lett.  2004,  14:  5803 

2a Ganesan R. Jelakovic S. Campbell AJ. Li ZZ. Asgian JL. Powers JC. Grüter MG. Biochemistry  2006,  45:  9059 

2b Helten H. Schirmeister T. Engels B. J. Phys. Chem. A  2004,  108:  7691 

2c Schirmeister T. Klockow A. Mini Rev. Med. Chem.  2003,  3:  585 

3a Wessjohann LA. Brandt W. Thiemann T. Chem. Rev.  2003,  103:  1625 

3b Salaün J. Top. Curr. Chem.  2000,  207:  1 

4a Zhuo J. Burns DM. Zhang C. Xu M. Weng L. Qian D.-Q. He C. Lin Q. Li Y.-L. Shi E. Agrios C. Metcalf B. Yao W. Synlett  2007,  460 

4b Yao W. Zhuo J. Burns DM. Xu M. Zhang C. Li Y.-L. Qian D.-Q. He C. Weng L. Shi E. Lin Q. Agrios C. Burn TC. Caulder E. Covington MB. Fridman JS. Friedman S. Katiyar K. Hollis G. Li Y. Liu C. Liu X. Marando CA. Newton R. Pan M. Scherle P. Taylor N. Vaddi K. Wasserman ZR. Wynn R. Yeleswaram S. Jalluri R. Bower M. Zhou B.-B. Metcalf B. J. Med. Chem.  2007,  50:  603 

4c Hillier MC. Davidson JP. Martin SF. J. Org. Chem.  2001,  66:  1657 

5 Nowak I. Robins MJ. J. Org. Chem.  2006,  71:  8876 

6a Stammer CH. Tetrahedron  1990,  46:  2231 

6b Burgess K. Ho K.-K. Moye-Sherman D. Synlett  1994,  575 

7 Bertus P. Szymoniak J. Synlett  2007,  1346 

8 Laroche C. Behr J.-B. Szymoniak J. Bertus P. Schütz C. Vogel P. Plantier-Royon R. Bioorg. Med. Chem.  2006,  14:  4047 

9a Davis BG. Hull A. Smith C. Nash RJ. Watson AA. Winkler DA. Griffiths RC. Fleet GWJ. Tetrahedron: Asymmetry  1998,  9:  2947 

9b Shilvock JP. Wheatley JR. Nash RJ. Watson AA. Griffiths RC. Butters TD. Müller M. Watkin DJ. Winkler DA. Fleet GWJ. J. Chem. Soc., Perkin Trans. 1  1999,  2735 

For pyrrolidine-type inhibitors of rhamnosidase­ (naringinase), see:

9c Kim JH. Curtis-Long MJ. Seo WD. Lee JH. Lee BW. Yoon YJ. Kang KY. Park KH. Bioorg. Med. Chem. Lett.  2005,  15:  4282 

9d Provencher L. Steensma DH. Wong C.-H. Bioorg. Med. Chem.  1994,  2:  1179 

10 For a synthesis of the d-enantiomer of 6, see: Redlich H. Kölln O. Synthesis  1995,  1383 

Aldehyde 7 has already been synthesized in either the d- or the l-series, see:

11a Zinner H. Kristen H. Chem. Ber.  1969,  97:  1654 

11b Allevi P. Ciuffreda P. Taroco G. Anastasia M. Tetrahedron: Asymmetry  1995,  6:  2357 

12 Bertus P. Szymoniak J. Chem. Commun.  2001,  1792 

13 Bertus P. Szymoniak J. J. Org. Chem.  2002,  67:  3965 

14 Lewis acids are used to cleave acetal protecting groups, see: Greene TW. Wuts PGM. Protecting Groups in Organic Synthesis   3rd ed.:  Wiley-Interscience; New York: 1999. 

15 Bertus P. Szymoniak J. J. Org. Chem.  2003,  68:  7133 

16 Laroche C. Behr J.-B. Szymoniak J. Bertus P. Plantier-Royon R. Eur. J. Org. Chem.  2005,  5084 

17 Chaplinski V. Winsel H. Kordes M. de Meijere A. Synlett  1997,  111 

18 Bertus P. Szymoniak J. Org. Lett.  2007,  9:  659 

19 The use of less than 1.5 equivalents of [TiMe(Oi-Pr)₃] resulted in incomplete conversion of 8

20a Behr J.-B. Mvondo-Evina C. Phung N. Guillerm G. J. Chem. Soc., Perkin Trans. 1  1997,  1597 

20b Behr J.-B. Guillerm G. Tetrahedron: Asymmetry  2002,  13:  111 

21 Reetz MT. Westermann J. Steinbach R. Wenderoth B. Peter R. Ostarek R. Maus S. Chem. Ber.  1985,  118:  1421